Tel Aviv - Delayed Quote ILA

Lineage Cell Therapeutics, Inc. (LCTX.TA)

Compare
217.10
+4.60
+(2.16%)
At close: January 12 at 3:49:21 PM GMT+2

Insider Purchases Last 6 Months

SharesTransactions
Purchases 0 0
Sales -- 0
Net Shares Purchased (Sold) 0 0
Total Insider Shares Held 832.77k --
% Net Shares Purchased (Sold) -- --

Net Institutional Purchases Prior Quarter to Latest Quarter

Shares
Net Shares Purchased (Sold) --
% Change in Institutional Shares Held --

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDate
SAMUEL GEORGE A. III General Counsel Purchase at price 0.60 per share. Direct 9,000 Nov 26, 2024
HOWE JILL ANN Chief Financial Officer Purchase at price 0.59 per share. Direct 8,850 Nov 26, 2024
MULROY MICHAEL H Director Purchase at price 0.57 per share. Direct 22,640 Nov 22, 2024
CULLEY BRIAN M Chief Executive Officer Purchase at price 0.60 per share. Direct 24,000 Nov 21, 2024
HOWE JILL ANN Chief Financial Officer Purchase at price 0.89 per share. Direct 9,345 Aug 16, 2024
CULLEY BRIAN M Chief Executive Officer Purchase at price 1.05 per share. Direct 10,500 May 24, 2024
CULLEY BRIAN M Chief Executive Officer -- Direct -- Feb 9, 2024
SAMUEL GEORGE A. III General Counsel -- Direct -- Feb 9, 2024
BAILEY DON MATTHEW Director Purchase at price 1.04 per share. Indirect 100,001 Feb 8, 2024
BROADWOOD PARTNERS, L.P. Director and Beneficial Owner of more than 10% of a Class of Security Purchase at price 1.04 per share. Direct 7,000,001 Feb 6, 2024
JAYASURIYA ANULA Director Purchase at price 1.09 per share. Direct 10,900 Dec 29, 2023
CULLEY BRIAN M Chief Executive Officer -- Direct -- Feb 10, 2023
HOGGE GARY S Officer -- Direct -- Feb 10, 2023
SAMUEL GEORGE A. III General Counsel -- Direct -- Feb 10, 2023

Related Tickers